ctrl K

AI Score

Unlock

Lipella Pharmaceuticals I... (LIPO)

AI Score

Unlock

2.55

-0.17 (-6.25%)

At close: Mar 28, 2025, 3:59 PM

2.56

0.51%

After-hours: Mar 28, 2025, 06:30 PM EDT

Lipella Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	449.62K	184.16K	259.35K	961.68K	694.75K
Cost of Revenue	3.04M	2.55M	1.46M	975.96K	682.89K
Gross Profit	-2.59M	-2.36M	-1.2M	-14.28K	11.86K
Operating Income	-4.75M	-2.59M	-1.92M	-56.86K	-53.79K
Interest Income	137.84K	1.68K	104.00	3.17K	334.00
Pretax Income	-4.62M	-2.6M	-1.87M	-61.66K	-61.85K
Net Income	-4.62M	-2.6M	-1.87M	-66.45K	-61.85K
Selling & General & Admin	2.16M	226.19K	718.38K	42.59K	65.65K
Research & Development	3.04M	2.55M	1.46M	975.96K	682.89K
Other Expenses	n/a	-45	57.09K	n/a	n/a
Operating Expenses	2.16M	2.77M	2.18M	1.02M	748.54K
Interest Expense	10.85K	9.61K	6.83K	7.96K	8.39K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.2M	2.77M	2.18M	1.02M	748.54K
Income Tax	n/a	-1.63K	6.73K	4.79K	-53.79K
Shares Outstanding (Basic)	749.83K	5.74M	5.74M	5.69M	5.69M
Shares Outstanding (Diluted)	750.38K	5.74M	5.74M	5.69M	5.69M
EPS (Basic)	-6.16	-0.45	-0.33	-0.01	-0.01
EPS (Diluted)	-6.16	-0.45	-0.33	-0.01	-0.01
EBITDA	-4.61M	-2.59M	n/a	-53.69K	334.00
Depreciation & Amortization	1.69K	2.59M	1.92M	56.86K	53.79K